Nichole R Klatt1, Jason M Brenchley. 1. Immunopathogenesis Unit, Laboratory of Molecular Microbiology, National Institute of Allergy and Infectious Diseases/NIH, 9000 Rockville Pike, Bethesda, MD 20892, USA.
Abstract
PURPOSE OF REVIEW: Th17 cells are a newly identified subtype of CD4 T cells that respond to bacterial and fungal antigens and are important in mucosal immunology. Because HIV infection results in loss of CD4 T cells as well as disruption to the gastrointestinal tract that causes microbial translocation and immune activation, Th17 cells potentially play an important role in HIV pathogenesis. Here we examine the relationship between Th17 cells and HIV disease pathogenesis. RECENT FINDINGS: Th17 cells are preferentially lost from the gastrointestinal tract of HIV-infected individuals, which is not entirely due to direct infection, as Th17 cells can be infected in vivo, but are not preferentially infected. Long-term highly active antiretroviral therapy (HAART) can result in restoration of Th17 cells in the gastrointestinal, which may be associated with better disease prognosis. Furthermore, other cells, such as Vdelta1 T cells, can make IL-17 in vivo during HIV infection and may contribute to antibacterial immunity after loss of Th17 cells. SUMMARY: Recent studies have improved our understanding of the role for Th17 cells during HIV infection; however, more studies are needed to discern better the detrimental consequences of loss of Th17 cells during HIV infection.
PURPOSE OF REVIEW: Th17 cells are a newly identified subtype of CD4 T cells that respond to bacterial and fungal antigens and are important in mucosal immunology. Because HIV infection results in loss of CD4 T cells as well as disruption to the gastrointestinal tract that causes microbial translocation and immune activation, Th17 cells potentially play an important role in HIV pathogenesis. Here we examine the relationship between Th17 cells and HIV disease pathogenesis. RECENT FINDINGS: Th17 cells are preferentially lost from the gastrointestinal tract of HIV-infected individuals, which is not entirely due to direct infection, as Th17 cells can be infected in vivo, but are not preferentially infected. Long-term highly active antiretroviral therapy (HAART) can result in restoration of Th17 cells in the gastrointestinal, which may be associated with better disease prognosis. Furthermore, other cells, such as Vdelta1 T cells, can make IL-17 in vivo during HIV infection and may contribute to antibacterial immunity after loss of Th17 cells. SUMMARY: Recent studies have improved our understanding of the role for Th17 cells during HIV infection; however, more studies are needed to discern better the detrimental consequences of loss of Th17 cells during HIV infection.
Authors: Teresa Zelante; Antonella De Luca; Pierluigi Bonifazi; Claudia Montagnoli; Silvia Bozza; Silvia Moretti; Maria L Belladonna; Carmine Vacca; Carmela Conte; Paolo Mosci; Francesco Bistoni; Paolo Puccetti; Robert A Kastelein; Manfred Kopf; Luigina Romani Journal: Eur J Immunol Date: 2007-10 Impact factor: 5.532
Authors: Jeffrey M Milush; Jacqueline D Reeves; Shari N Gordon; Dejiang Zhou; Alagar Muthukumar; David A Kosub; Elizabeth Chacko; Luis D Giavedoni; Chris C Ibegbu; Kelly S Cole; John L Miamidian; Mirko Paiardini; Ashley P Barry; Silvija I Staprans; Guido Silvestri; Donald L Sodora Journal: J Immunol Date: 2007-09-01 Impact factor: 5.422
Authors: Shari N Gordon; Nichole R Klatt; Steven E Bosinger; Jason M Brenchley; Jeffrey M Milush; Jessica C Engram; Richard M Dunham; Mirko Paiardini; Sara Klucking; Ali Danesh; Elizabeth A Strobert; Cristian Apetrei; Ivona V Pandrea; David Kelvin; Daniel C Douek; Silvija I Staprans; Donald L Sodora; Guido Silvestri Journal: J Immunol Date: 2007-09-01 Impact factor: 5.422
Authors: Ivona V Pandrea; Rajeev Gautam; Ruy M Ribeiro; Jason M Brenchley; Isolde F Butler; Melissa Pattison; Terri Rasmussen; Preston A Marx; Guido Silvestri; Andrew A Lackner; Alan S Perelson; Daniel C Douek; Ronald S Veazey; Cristian Apetrei Journal: J Immunol Date: 2007-09-01 Impact factor: 5.422
Authors: Chun Kwok Wong; Lydia Choi Wan Lit; Lai Shan Tam; Edmund Kwok Ming Li; Purple Tsz Yan Wong; Christopher Wai Kei Lam Journal: Clin Immunol Date: 2008-03-25 Impact factor: 3.969
Authors: Manuela Raffatellu; Renato L Santos; David E Verhoeven; Michael D George; R Paul Wilson; Sebastian E Winter; Ivan Godinez; Sumathi Sankaran; Tatiane A Paixao; Melita A Gordon; Jay K Kolls; Satya Dandekar; Andreas J Bäumler Journal: Nat Med Date: 2008-03-23 Impact factor: 53.440
Authors: Afam Okoye; Martin Meier-Schellersheim; Jason M Brenchley; Shoko I Hagen; Joshua M Walker; Mukta Rohankhedkar; Richard Lum; John B Edgar; Shannon L Planer; Alfred Legasse; Andrew W Sylwester; Michael Piatak; Jeffrey D Lifson; Vernon C Maino; Donald L Sodora; Daniel C Douek; Michael K Axthelm; Zvi Grossman; Louis J Picker Journal: J Exp Med Date: 2007-08-27 Impact factor: 14.307
Authors: Natalie L Wilson; David E Vance; Linda D Moneyham; James L Raper; Michael J Mugavero; Sonya L Heath; Mirjam-Colette Kempf Journal: J Assoc Nurses AIDS Care Date: 2014-07-22 Impact factor: 1.354
Authors: Nichole R Klatt; Lauren A Canary; Xiaoyong Sun; Carol L Vinton; Nicholas T Funderburg; David R Morcock; Mariam Quiñones; Clayton B Deming; Molly Perkins; Daria J Hazuda; Michael D Miller; Michael M Lederman; Julie A Segre; Jeffrey D Lifson; Elias K Haddad; Jacob D Estes; Jason M Brenchley Journal: J Clin Invest Date: 2013-01-16 Impact factor: 14.808
Authors: Haitao Hu; Martin Nau; Phil Ehrenberg; Agnes-Laurence Chenine; Camila Macedo; Yu Zhou; Z John Daye; Zhi Wei; Maryanne Vahey; Nelson L Michael; Jerome H Kim; Mary Marovich; Silvia Ratto-Kim Journal: Blood Date: 2012-12-20 Impact factor: 22.113